Get the Stockscreener App
2.56
0.39%
-0.010
After Hours:
2.56
Sintx Technologies Inc stock is traded at $2.56, with a volume of 8,500.
It is down -0.39% in the last 24 hours and down -12.93% over the past month.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
See More
Previous Close:
$2.57
Open:
$2.62
24h Volume:
8,500
Relative Volume:
0.23
Market Cap:
$9.86M
Revenue:
$1.27M
Net Income/Loss:
$-9.84M
P/E Ratio:
-0.3694
EPS:
-6.9309
Net Cash Flow:
$-7.64M
1W Performance:
-3.76%
1M Performance:
-12.93%
6M Performance:
-43.61%
1Y Performance:
-14.09%
1-Day Range:
$2.55
$2.63
1-Week Range:
$2.35
$2.63
52-Week Range:
$1.71
$6.78
Sintx Technologies Inc Stock (SINT) Company Profile
Name
Sintx Technologies Inc
Sector
Industry
Phone
801-839-3516
Address
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.56 | 9.90M | 1.27M | -9.84M | -7.64M | -6.9309 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-19 | Initiated | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Stock (SINT) Latest News
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - Orthopedics This Week
SINTX completes first human implant, names new president By Investing.com - Investing.com Australia
Sintx Technologies 2025 10‑K: Revenue $1.018M, Net Loss $10.364M - TradingView
SINTX completes first human implant, names new president - Investing.com
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Sintx Technologies (SINT) to Release Quarterly Earnings on Monday - Defense World
SINTX Technologies: Advanced Silicon Nitride Ceramics for Biomedical, Technical, and Antipathogenic Applications 72 - Minichart
Sintx Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SINTX Technologies (NASDAQ: SINT) outlines 2025 losses, cash and silicon nitride strategy - Stock Titan
SINTX completes first surgery with foot and ankle implant system By Investing.com - Investing.com India
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Orthopedics This Week
SINTX Technologies (SINT) Achieves Milestone with First Surgical Use of New System - GuruFocus
SINTX completes first surgery with foot and ankle implant system - Investing.com
Sintx Technologies announces first-in-human surgery using FDA-cleared Sinaptic® Foot & Ankle Implant - marketscreener.com
A new foot implant reaches its first patient after FDA clearance - Stock Titan
Sintx Technologies (SINT) president granted 107,143 RSUs under 2025 equity plan - Stock Titan
SINT PE Ratio & Valuation, Is SINT Overvalued - Intellectia AI
SINTX Technologies Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Published on: 2026-03-11 05:25:53 - baoquankhu1.vn
Sintx Technologies director Lyons buys shares worth $24,092 By Investing.com - Investing.com South Africa
Sintx Technologies director Lyons buys shares worth $24,092 - Investing.com
Director Lyons adds 8,292 Sintx Technologies (SINT) shares in open-market buys - Stock Titan
Earnings Beat: What is the PEG ratio of Sintx Technologies Inc2025 Winners & Losers & Free Reliable Trade Execution Plans - baoquankhu1.vn
SINTX focuses on filament and partnerships: New president to bring SiN/PEEK into 3D production - 3Druck.com
SINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SINTX Technologies names Ryan Elmore President to drive commercial expansion of SiN biomaterials - VoxelMatters
Published on: 2026-03-02 05:18:20 - baoquankhu1.vn
SINTX Technologies signs with Evonik to produce SiN/PEEK compound for 3D printed implants - VoxelMatters
SINTX Technologies acquires SiNAPTIC Surgical assets to enter foot and ankle fusion market - VoxelMatters
SINT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SINTX Technologies Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Insider Buying: Jay Moyes Acquires Additional Shares of SINTX Te - GuruFocus
Sintx Technologies director Moyes buys $2910 in shares - Investing.com
What is the PEG ratio of Sintx Technologies Inc.Trade Volume Summary & High Accuracy Trade Alerts - mfd.ru
Is Sintx Technologies Inc. (1110) stock a buy for dividend portfoliosStop Loss & Reliable Intraday Trade Plans - mfd.ru
Sintx Technologies director Anderson buys $9,060 in stock - Investing.com Australia
Sintx Technologies director Anderson buys $9,060 in stock By Investing.com - Investing.com South Africa
Insider Buying: Mark Anderson Acquires Additional Shares of SINTX Technologies Inc (SINT) - GuruFocus
SINTX Technologies appoints Ryan Elmore as president - Investing.com Nigeria
Sintx Technologies Appoints Ryan Elmore as New President - TipRanks
Sintx Technologies, Inc. Announces Cessation of Eric Olson as President, Effective March 16, 2026 - marketscreener.com
Sintx Technologies, Inc. Appoints Ryan Elmore as President, Effective March 16, 2026 - marketscreener.com
SINT Appoints Ryan Elmore as President, Effective March 2026 - GuruFocus
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms - The Manila Times
Treasury Yields: Is National Healthcare Properties Inc stock risky to hold nowEarnings Overview Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
How sustainable is Sintx Technologies Inc. stock dividend payoutEarnings Miss & Weekly High Momentum Picks - mfd.ru
Published on: 2026-02-12 18:49:12 - baoquankhu1.vn
Sintx Technologies (SINT) CFO awarded 60,000 RSUs under 2025 equity plan - Stock Titan
CEO Moves: What is Sintx Technologies Incs market positionEarnings Growth Summary & Risk Managed Trade Strategies - baoquankhu1.vn
Sintx Technologies Inc Stock (SINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):